Financials • Specialty Insurers
$19.82 ▲ +0.01
(+0.05%)
MKT CAP: $4.30B • VOL: 582.7K
52W L $9 52W H $20
ROARABLE / RQD
C • 64/100
PIOTROSKI
3 / 9
ARX // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $912.9M | $602.6M | $344.0M |
| YoY Revenue Growth % | +51.5% | +75.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $0 | $0 | $0 |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $445.1M | $785.7M | $290.0M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $445.1M | $785.7M | $290.0M |
| FCF Margin % | 48.8% | 80.0% | 80.0% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | $1.72B | $1.23B | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $697.7M | $304.3M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ARX.